logo
ResearchBunny Logo
High Prevalence of Respiratory Co-Infections and Risk Factors in COVID-19 Patients at Hospital Admission During an Epidemic Peak in China

Medicine and Health

High Prevalence of Respiratory Co-Infections and Risk Factors in COVID-19 Patients at Hospital Admission During an Epidemic Peak in China

X. Zhu, F. Tian, et al.

This intriguing study evaluated 716 COVID-19 patients in a Chinese hospital, revealing a staggering 76.82% co-infection rate with 11 pathogens, predominantly bacterial. The most common culprits were *Streptococcus pneumoniae* and *Haemophilus influenzae*. With insights on mortality risk factors such as dyspnea and *Mycoplasma pneumoniae* co-infection, researchers stress the importance of better antibiotic management. This vital work was conducted by Xiaoying Zhu, Fengqin Tian, Yulei Li, Qunfeng Lu, Qinqin Long, Xidai Long, and Demin Cao.... show more
Abstract
Background: Recent research highlights the contribution of co-infections to elevated disease severity and mortality among COVID-19 patients. Given China's decision to ease epidemic prevention policies in December 2022, a comprehensive exploration of the risks and characteristics of co-infections with respiratory pathogens becomes imperative. Methods: We conducted a retrospective analysis of 716 COVID-19 patients admitted to a primary hospital in China. The detection of twelve respiratory pathogens was conducted using qPCR, and the potential risk factors were analyzed through Cox regression analysis. Results: Within this cohort, 76.82% of cases exhibited co-infection involving eleven distinct pathogens. Among these, bacterial co-infections were observed in 74% of cases, with Streptococcus pneumoniae and Haemophilus influenzae emerging as the most prevalent bacterial co-infection agents. Additionally, 15% of cases presented with viral co-infections, predominantly involving influenza A virus and respiratory syncytial virus. Nevertheless, our investigation suggested that there might be some inappropriate antibiotic use in treatments. Furthermore, risk analysis unveiled dyspnea, hypoproteinemia, low lymphocyte counts, and co-infection with Mycoplasma pneumoniae as prominent risk factors for COVID-19 inpatients. Conclusion: Our findings underscore a significant occurrence of co-infections among COVID-19 patients during the epidemic, emphasizing the need for enhanced antibiotic stewardship. Effective management strategies should encompass respiratory status, nutritional aspects, and vigilance towards co-infections involving M. pneumoniae during COVID-19 treatment. This study underscores the significance of comprehensive management protocols to address the multifaceted challenges presented by co-infections in COVID-19 patients.
Publisher
Infection and Drug Resistance
Published On
Oct 25, 2023
Authors
Xiaoying Zhu, Fengqin Tian, Yulei Li, Qunfeng Lu, Qinqin Long, Xidai Long, Demin Cao
Tags
COVID-19
co-infection
bacterial pathogens
mortality risk factors
antibiotic stewardship
Streptococcus pneumoniae
Mycoplasma pneumoniae
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny